Shukra Pharmaceuticals Q1 Results
- BSE: 524632
- NSE: SHUKRAPHAR
- ISIN: INE551C01044
- Sector: Biotechnology & Drugs
BSE
53.94
0.02 (0.04%)
0.02 (0.04%)Volume2.97 L
Updated: Fri 11 Sep, 2026 | 15:52:30
NSE
54.000.03 (0.06%)
0.03 (0.06%)Volume1.58 M
Updated: Fri 11 Sep, 2026 | 15:29:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹23.52 Cr.(336.32%)
- Operating Profit₹18.06 Cr.(3298.87%)
- Profit After Tax₹12.96 Cr.(1158.72%)
- Operating Margin76.79%(678.99%)
Note: Comparison is on YoY basis
Quarterly - Shukra Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 25 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5.46 | 6.62 | -17.56% | 4.86 | 12.37% |
| Depreciation/ Amortization | 1.08 | 1.01 | 7.44% | 0.79 | 37.51% |
| Operating Income | 18.06 | -0.32 | 0.00% | 0.53 | 3298.87% |
| Net Income | 12.96 | -1.73 | 0.00% | 1.03 | 1158.72% |
| Other Operating Expenses Total | 1.52 | -0.70 | 0.00% | 1.48 | 3.22% |
| Net Income Before Taxes | 18.17 | 0.37 | 4844.71% | 1.37 | 1223.51% |
| Total Revenue | 23.52 | 6.30 | 273.20% | 5.39 | 336.32% |
| Selling/ General/ Admin Expenses Total | 4.39 | 0.37 | 1080.39% | 1.82 | 140.49% |
| Diluted Normalized EPS | 0.30 | -0.04 | 0.00% | 0.02 | 1400.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.